Literature DB >> 2838380

Expression of an activated ras gene causes developmental abnormalities in transgenic Drosophila melanogaster.

J G Bishop1, V G Corces.   

Abstract

We describe the developmental effects of the expression of a normal and mutated Drosophila ras gene ras2 in transgenic Drosophila. A Gly14----Val14 mutant (Gly14 in ras2 is equivalent to Gly12 in mammalian ras proteins) was constructed in ras2 by site-directed mutagenesis. Inducible constructs of ras2 and ras2Val14 were made by coupling the hsp70 promoter to each of the genes. In addition, the endogenous ras2 promoter was placed upstream of the mutated ras2Val14. These constructs were introduced into the germ line of Drosophila to yield transgenic lines by P-element-mediated transformation. A wide variety of developmental disorders were displayed in flies carrying the mutated ras2 gene driven by either the endogenous or the hsp70 promoter. The basal level of transcription of mutated ras from the uninduced hsp70 promoter was sufficient to produce disturbances in the development of several tissue types. In contrast, phenotypic disturbances were not seen with the normal ras2 gene driven by the hsp70 promoter even when induced by heat shock to very high levels of transcription over normal ras2 levels. A subset of the tissues expressing ras2 during development was particularly sensitive to the expression of ras2Val14. The compound eye was found to develop a dorsal-to-ventral 'scar' correlated with the wave of differentiation occurring in the eye imaginal disc at the time of a single brief induction of the hsp70 promoted ras2Val14 construct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838380     DOI: 10.1101/gad.2.5.567

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  16 in total

1.  Biochemical characterization of Artemia ras p21.

Authors:  A Gandarillas; J Renart; M Quintanilla
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

2.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

3.  The arflike gene encodes an essential GTP-binding protein in Drosophila.

Authors:  J W Tamkun; R A Kahn; M Kissinger; B J Brizuela; C Rulka; M P Scott; J A Kennison
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  A genetic analysis of the 63E-64A genomic region of Drosophila melanogaster: identification of mutations in a replication factor C subunit.

Authors:  S D Harrison; N Solomon; G M Rubin
Journal:  Genetics       Date:  1995-04       Impact factor: 4.562

5.  Local transposition of P elements in Drosophila melanogaster and recombination between duplicated elements using a site-specific recombinase.

Authors:  K G Golic
Journal:  Genetics       Date:  1994-06       Impact factor: 4.562

6.  The Drosophila tom retrotransposon encodes an envelope protein.

Authors:  S Tanda; J L Mullor; V G Corces
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Differential activity of Ras1 during patterning of the Drosophila dorsoventral axis.

Authors:  J D Schnorr; C A Berg
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

8.  A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.

Authors:  A M Chan; T Miki; K A Meyers; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  A highly conserved sequence in the 3'-untranslated region of the drosophila Adh gene plays a functional role in Adh expression.

Authors:  J Parsch; W Stephan; S Tanda
Journal:  Genetics       Date:  1999-02       Impact factor: 4.562

10.  lingerer, a Drosophila gene involved in initiation and termination of copulation, encodes a set of novel cytoplasmic proteins.

Authors:  Hisato Kuniyoshi; Kotaro Baba; Ryu Ueda; Shunzo Kondo; Wakae Awano; Naoto Juni; Daisuke Yamamoto
Journal:  Genetics       Date:  2002-12       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.